Gait Analysis in MPS IVA
| Status: | Recruiting |
|---|---|
| Conditions: | Orthopedic, Metabolic |
| Therapuetic Areas: | Pharmacology / Toxicology, Orthopedics / Podiatry |
| Healthy: | No |
| Age Range: | 1 - Any |
| Updated: | 4/2/2016 |
| Start Date: | August 2013 |
| End Date: | July 2016 |
Gait Analysis in Patients With MPS IVA Treated With Enzyme Replacement Therapy
The purpose of this study is to learn about gait (walking) characteristics in MPS IVA and
possible changes in gait with enzyme replacement therapy.
possible changes in gait with enzyme replacement therapy.
The purpose of this 3-year study is to conduct a longitudinal investigation using motion
analysis of gait to objectively and quantitatively assess gait characteristics of MPS IVA
patients. Data documenting gait characteristics and abnormalities will be gathered in
patients initiating enzyme replacement therapy.
Inclusion criteria Individuals with MPS IVA diagnosed by enzyme or molecular studies
Exclusion Criteria Individual with MPS IVA previously enrolled in BMN-110 Individual is
non-ambulatory The individual is unable to complete longitudinal study visits at least
yearly
analysis of gait to objectively and quantitatively assess gait characteristics of MPS IVA
patients. Data documenting gait characteristics and abnormalities will be gathered in
patients initiating enzyme replacement therapy.
Inclusion criteria Individuals with MPS IVA diagnosed by enzyme or molecular studies
Exclusion Criteria Individual with MPS IVA previously enrolled in BMN-110 Individual is
non-ambulatory The individual is unable to complete longitudinal study visits at least
yearly
Inclusion Criteria:
-Diagnosis of MPS IVA
Exclusion Criteria:
Non-ambulatory
- Previous enrolled in clinical trial BMN-110
We found this trial at
1
site
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
Portland, Oregon 97239
503 494-8311
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
Click here to add this to my saved trials
